Co-Authors
This is a "connection" page, showing publications co-authored by Giselle Mosnaim and Matthew Greenhawt.
Connection Strength
1.460
-
The Risk of Allergic Reaction to SARS-CoV-2 Vaccines and Recommended Evaluation and Management: A Systematic Review, Meta-Analysis, GRADE Assessment, and International Consensus Approach. J Allergy Clin Immunol Pract. 2021 10; 9(10):3546-3567.
Score: 0.238
-
Media Influence on Anxiety, Health Utility, and Health Beliefs Early in the SARS-CoV-2 Pandemic-a Survey Study. J Gen Intern Med. 2021 05; 36(5):1327-1337.
Score: 0.233
-
A Phased Approach to Resuming Suspended Allergy/Immunology Clinical Services. J Allergy Clin Immunol Pract. 2020 Jul - Aug; 8(7):2125-2134.
Score: 0.221
-
Health and Economic Outcomes of Home Maintenance Allergen Immunotherapy in Select Patients with High Health Literacy during the COVID-19 Pandemic: A Cost-Effectiveness Analysis During Exceptional Times. J Allergy Clin Immunol Pract. 2020 Jul - Aug; 8(7):2310-2321.e4.
Score: 0.220
-
Reply to "Subcutaneous terbutaline as an alternative to aerosolized albuterol". J Allergy Clin Immunol Pract. 2020 Jul - Aug; 8(7):2450-2452.
Score: 0.220
-
COVID-19: Pandemic Contingency Planning for the Allergy and Immunology Clinic. J Allergy Clin Immunol Pract. 2020 05; 8(5):1477-1488.e5.
Score: 0.218
-
Reply to "Challenges to pediatric services during COVID-19 pandemic: A London, UK perspective". J Allergy Clin Immunol Pract. 2020 09; 8(8):2835-2836.
Score: 0.056
-
Clinician Wellness During the COVID-19 Pandemic: Extraordinary Times and Unusual Challenges for the Allergist/Immunologist. J Allergy Clin Immunol Pract. 2020 06; 8(6):1781-1790.e3.
Score: 0.055